Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Eylea
Pharma
Roche's juggernaut Vabysmo routs analyst consensus
In the first quarter, Roche's Vabysmo racked up sales of 847M Swiss francs, which was up 108% and demolished analysts' consensus.
Kevin Dunleavy
Apr 24, 2024 11:29am
DOJ sues Regeneron for under-reporting Eylea price to Medicare
Apr 11, 2024 11:12am
Ad astra: Regeneron launches stargazing-themed Eylea HD campaign
Mar 20, 2024 10:46am
Appeals court backs Regeneron's antitrust suit against Novartis
Mar 19, 2024 10:40am
Regeneron touts 'favorable' physician reports on Eylea HD
Feb 2, 2024 11:09am
Viatris' Eylea biosimilar knocked down by patent court
Dec 29, 2023 10:01am